Table 1.
Target gene | Oligonucleotide sequence [5′-3′] | Amplicon length | |
---|---|---|---|
Staphylococcus aureus (MRSA) | |||
SA fwd3 | mecA | TCCAACATGAAGATGGCTATCGTGTCACAATCGTT | 193 bp |
SA rev3 | CCTGTTTGAGGGTGGATAGCAGTACCTGAGCC | ||
Salmonella enterica | |||
SE fwd1 | invA | TACCGGGCATACCATCCAGAGAAAATCGGGCCGC | 133 bp |
SE rev2 | ATTGGCGATAGCCTGGCGGTGGGTTTTGTTGT | ||
Neisseria gonorrhoeae | |||
NG fwd3 | fit | CAACGCAATCAAATTCCGTGCGCGAGCCGCAG | 165 bp |
NG rev2 | CCGCGTACGTCTTCCAGCTCAACACCTCCGAT | ||
Plasmid control | |||
PC fwd5 | Plasmid control | ATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGT | 227 bp |
PC rev6 | CAGCAACGCGGCCTTTTTACGGTTCCTGGCCTT |
For on-chip RPA experiments forward primers were modified with a 5′ NH2-(CH2)6-linker to allow the covalent attachment to the chip surface. Reverse primers in on-chip RPA experiments contain a 5′ Cy5-modification for signal generation